Table 1 Clinical and metabolic characteristics of the study group
From: The impact of IGF-I, puberty and obesity on early retinopathy in children: a cross-sectional study
Males/females (n°) | 115/150 |
Prepubertal/Pubertal (n°) | 43/222 |
Age (years) | 13.04 ± 1.9 |
BMI SDS (Italy) | 2.17 ± 0.5 |
Waist/height ratio | 0.62 ± 0.05 |
Systolic blood pressure (mmHg) | 120.5 ± 10.1 |
Diastolic blood pressure (mmHg) | 67.08 ± 9.4 |
Fasting glucose (mg/dl) | 85.53 ± 7.3 |
Fasting insulin (mU/L) | 25.60 ± 17.2 |
Fasting C peptide (ng/ml) | 2.07 ± 0.8 |
HOMA-IR | 5.48 ± 3.9 |
QUICKI | 0.31 ± 0.02 |
AUC glucose (mg/min/ml) | 13,948.33 ± 2053 |
AUC insulin (microUI/min/ml) | 17,154.3 ± 9057.2 |
AUC C peptide (ng/min/ml) | 838.44 ± 307.8 |
HDL cholesterol (mg/dl) | 46.78 ± 10.3 |
Triglycerides (mg/dl) | 92.14 ± 52.3 |
C-reactive protein (mg/dl) | 0.42 ± 0.7 |
IGF-I SDS | −0.64 ± 1.01 |